Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

CNU IR > Pharmacy and Science > 2017 > Item 310902800/33606

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/33606

Title:	Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Authors:	蔡承宏方嘉德
Contributors:	藥學系
Keywords:	cardiovascular disease phase III study SGLT2 inhibitor type 2 diabetes
Date:	2017
Issue Date:	2022-01-25 14:52:03 (UTC+8)
Abstract:	確認Empagliflozin 藥物對第二型糖尿病患者在血壓、動脈硬化及血管阻力的影響。統計第III 期臨床試驗數據的第二型糖尿病病人患有高血壓而且接受Empagliflozin 藥物的事後分析，發現Empagliflozin 能夠降低血壓並且對動脈硬化以及血管阻力有較好的影響。
Relation:	2017 第十一屆嘉南藥理大學藥理學院師生研究成果發表會，起迄日：2017/05/02-2017/05/04
Appears in Collections:	[Pharmacy and Science] 2017 [Dept. of Pharmacy] Proceedings

Files in This Item:

File	Size	Format
B22.pdf	768Kb	Adobe PDF	131	View/Open